Persons | Marinebiotech


[ report an error in this record ] Print this page


Avda. De los Reyes, 1
Pol. Ind. La Mina-Norte
28770-Colmenar Viejo

Tel.: +34-(0)91-846 60 00
Fax: +34-(0)91-846 60 01
 Persons | Projects 
Type: Scientific

Persons (2)  Top | Projects 

PharmaMar is a Spanish member of the Zeltia Group, a leader in the development of antitumor drugs of marine origin.

The oceans cover 70% of the Earth's surface, and correspond to 90% of the biosphere. For millions of years, innumerable forms of marine life have evolved to produce an immense variety of chemical entities of exclusive sophistication. Among these, there are molecules with potent biological activities, developed as a form of biochemical warfare to survive in an extremely competitive environment. PharmaMar has identified the antitumour potential of these molecules, and is actively developing them as innovative treatments for cancer.

One of the company's commitments is to develop drugs to treat rare (""orphan"") diseases, i.e. those affecting under 5 out of every 100,000 people, according to the EU's definition. PharmaMar has a strong portfolio of marine origin compounds in development

We research to provide solutions that improve the quality of life of cancer patients and their families.

Projects (3)  Top | Persons 
  • MACUMBA: Marine Microorganisms: Cultivation Methods for Improving their Biotechnological Applications, more
  • MAMBA: Marine Metagenomics for New Biotechnological Applications, more
  • Micro B3: Marine Microbial Biodiversity, Bioinformatics and Biotechnology, more

All data in the Integrated Marine Information System (IMIS) is subject to the VLIZ privacy policy Top | Persons | Projects